Solid Biosciences (SLDB) EPS (Basic) (2017 - 2026)
Quarterly results put EPS (Basic) at -$0.52 for Q1 2026, up 11.86% from a year ago — trailing twelve months through Mar 2026 was -$1.95 (up 35.22% YoY), and the annual figure for FY2025 was -$1.99, up 34.97%.
Solid Biosciences has reported EPS (Basic) over the past 10 years, most recently at -$0.52 for Q1 2026.
- EPS (Basic) reached -$0.52 in Q1 2026 per SLDB's latest filing, up from -$0.53 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.42 in Q2 2025 and bottomed at -$3.37 in Q1 2022.
- Median EPS (Basic) over the past 5 years was -$0.79 (2024), compared with a mean of -$1.21.
- Peak annual rise in EPS (Basic) hit 72.36% in 2022, while the deepest fall reached 1858.82% in 2022.
- Over 5 years, EPS (Basic) stood at -$0.68 in 2022, then tumbled by 47.06% to -$1.0 in 2023, then dropped by 2.0% to -$1.02 in 2024, then surged by 48.04% to -$0.53 in 2025, then increased by 1.89% to -$0.52 in 2026.
- Business Quant data shows EPS (Basic) for SLDB at -$0.52 in Q1 2026, -$0.53 in Q4 2025, and -$0.48 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 4.06 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 6.99 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 0.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.55 |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.52 |
| Dec 31, 2025 | -0.53 |
| Sep 30, 2025 | -0.48 |
| Jun 30, 2025 | -0.42 |
| Mar 31, 2025 | -0.59 |
| Dec 31, 2024 | -1.02 |
| Sep 30, 2024 | -0.79 |
| Jun 30, 2024 | -0.61 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | -1.00 |
| Sep 30, 2023 | -1.05 |
| Jun 30, 2023 | -1.25 |
| Mar 31, 2023 | -1.54 |
| Dec 31, 2022 | -0.68 |
| Sep 30, 2022 | -2.71 |
| Jun 30, 2022 | -3.33 |
| Mar 31, 2022 | -3.37 |
| Dec 31, 2021 | -2.46 |
| Sep 30, 2021 | -2.40 |
| Jun 30, 2021 | -0.17 |
| Mar 31, 2021 | -0.19 |
| Dec 31, 2020 | -24.11 |
| Sep 30, 2020 | -0.44 |
| Jun 30, 2020 | -0.39 |
| Mar 31, 2020 | -0.56 |
| Dec 31, 2019 | -0.67 |
| Sep 30, 2019 | -0.67 |
| Jun 30, 2019 | -0.76 |
| Mar 31, 2019 | -0.85 |
| Dec 31, 2018 | -0.63 |
| Sep 30, 2018 | -0.55 |
| Jun 30, 2018 | -0.52 |
| Mar 31, 2018 | -0.54 |
| Dec 31, 2017 | -0.84 |
| Sep 30, 2017 | -0.79 |
| Jun 30, 2017 | -0.66 |
| Mar 31, 2017 | -0.01 |